AU2001255126A1 - The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure - Google Patents

The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure

Info

Publication number
AU2001255126A1
AU2001255126A1 AU2001255126A AU5512601A AU2001255126A1 AU 2001255126 A1 AU2001255126 A1 AU 2001255126A1 AU 2001255126 A AU2001255126 A AU 2001255126A AU 5512601 A AU5512601 A AU 5512601A AU 2001255126 A1 AU2001255126 A1 AU 2001255126A1
Authority
AU
Australia
Prior art keywords
glomerulosclerosis
angiotensin
aspartate
des
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255126A
Inventor
Meng Kwoon Sim
Chorh Chuan Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Singapore
Original Assignee
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Singapore filed Critical National University of Singapore
Publication of AU2001255126A1 publication Critical patent/AU2001255126A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001255126A 2000-04-13 2001-04-12 The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure Abandoned AU2001255126A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG200002037-0 2000-04-13
SG200002037 2000-04-13
PCT/SG2001/000061 WO2001078759A1 (en) 2000-04-13 2001-04-12 The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure

Publications (1)

Publication Number Publication Date
AU2001255126A1 true AU2001255126A1 (en) 2001-10-30

Family

ID=20430567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255126A Abandoned AU2001255126A1 (en) 2000-04-13 2001-04-12 The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure

Country Status (4)

Country Link
US (1) US7553928B2 (en)
JP (1) JP4911854B2 (en)
AU (1) AU2001255126A1 (en)
WO (1) WO2001078759A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981867B2 (en) * 2005-09-09 2011-07-19 National University Of Singapore Use of des-aspartate-angiotensin I
BRPI0800585B8 (en) * 2008-02-13 2021-05-25 Univ Minas Gerais pharmaceutical compositions of des-[asp1]-[ala1]-angiotensin-(1-7) peptide and use of des-[asp1]-[ala1]-angiotensin-(1-7) peptide
US8980250B2 (en) 2010-06-14 2015-03-17 Meng Kwoon Sim Use of des-aspartate-angiotensin I in inflammation-related pathologies and diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854388A (en) * 1993-06-24 1998-12-29 Washington State University Research Foundation Angiotensin IV peptides and receptor
SG68529A1 (en) 1995-05-25 1999-11-16 Univ Singapore The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
SG92610A1 (en) 1997-10-24 2002-11-19 Univ Singapore The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
CA2319701C (en) * 1998-02-09 2009-09-29 University Of Southern California Method of promoting erythropoiesis
US6902888B1 (en) * 1999-05-21 2005-06-07 Myriad Genetics, Inc. Diabetes gene

Also Published As

Publication number Publication date
JP2003531126A (en) 2003-10-21
US20030086920A1 (en) 2003-05-08
WO2001078759A1 (en) 2001-10-25
JP4911854B2 (en) 2012-04-04
US7553928B2 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2001260400A1 (en) Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
AUPR105400A0 (en) Processes and compositions for water treatment
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2001246877A1 (en) Remedies
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2001272100A1 (en) Use of tgf-beta antagonists to treat or to prevent loss of renal function
AU2001276149A1 (en) Cleaning and disinfecting agent
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU3863400A (en) Breathable absorbent articles having an oxidising agent
AU5056099A (en) Compounds for use in the treatment of inflammation
AU2001293891A1 (en) New combination for the treatment of asthma
AU2001253165A1 (en) Use of fluorocarbons for the prevention of surgical adhesions
AU2001239510A1 (en) Treatment of renal disorders
AU5262200A (en) Arrangement in ventilatory treatment of the lungs
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
PL349137A1 (en) Use of cholesterol-lowering agent
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001255126A1 (en) The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure
AU2001294183A1 (en) Waste treatment equipment